Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
47M
-
Shares change
-
+820K
-
Total reported value, excl. options
-
$105M
-
Value change
-
+$1.92M
-
Put/Call ratio
-
2.25
-
Number of buys
-
31
-
Number of sells
-
-27
-
Price
-
$2.23
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q3 2017
84 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q3 2017.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (10.3M shares), BlackRock Inc. (6.52M shares), VANGUARD GROUP INC (5.44M shares), JPMORGAN CHASE & CO (3.36M shares), FMR LLC (3.27M shares), NATIXIS (3.16M shares), Broadfin Capital, LLC (2.43M shares), STATE STREET CORP (1.88M shares), MILLENNIUM MANAGEMENT LLC (1.63M shares), and NORTHERN TRUST CORP (1.25M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.